Among Americans who have never taken GLP-1s but are considering beginning treatment in the next 12 months, 25.1% cite the pill option as the primary factor influencing their desire to begin treatment, and among the 9.3% of Americans who have discontinued GLP-1 treatments, 44.1% say they are considering resuming treatments because of pill options
Okay, but the most striking thing about this graph is the plateau
Previous: FAQs About Stevioside Navigation Phone: +86 151 5801 8208 +86 138 0570 9842 E-mail: Add.: ROOM 702, NO.318, HUAYUANGANG STREET, GONGSHU DISTRICT, HANGZHOU, ZHEJIANG, CHINA Request a Quote
Novo Nordisk has gone to lengths to make this process somewhat more approachable than traditional injectables by providing single-use injection pens that are pre-loaded with your prescribed dose
References 1 World Health Organization (WHO)